BASF Slips as Evonik Exit Hands the Floor to Jefferies' Bear Case
Published on 11/22/2026 at 18:31 | Editorial boerse-global.deBASF shares shed 2.6% on Friday to close at €49.45, caught in a downswing across German chemical equities that dpa-AFX linked to soft US market leads and a wave of analyst downgrades — most notably at Lanxess and Evonik. The retreat came barely a day after the Ludwigshafen group walked away from its pursuit of Evonik, a decision that had initially been greeted warmly: Reuters reported the stock climbed as much as 2.8% in the immediate aftermath of the withdrawal.
The takeover saga ended on Thursday, when BASF pulled the plug after Evonik turned down two unsolicited all-cash proposals. Its final offer stood at €24 per Evonik share. BASF argued that a richer price could not be justified given Evonik's standalone business prospects and the risks attached to them.
Sentiment on Friday was never going to be helped by Jefferies, which had cut BASF from "Hold" to "Underperform" on 11 November while keeping its €44 price target unchanged. Analyst Priyanka Patel pointed to eroding margins, excess capacity and higher gas prices, adding that demand has yet to show any meaningful recovery.
Should investors sell immediately? Or is it worth buying BASF?
Divestment and expansion move in parallel
Away from the Evonik question, BASF has been reshaping its portfolio. On 12 November it signed an agreement to sell its global mining solutions business to SNF. The package includes a production site in Cork, Ireland, and roughly 140 employees. BASF expects the transaction to close in 2027, subject to merger clearance from the relevant authorities and the usual conditions being met.
At the same time, the company is adding bulk in Louisiana. BASF officially commissioned its new MDI plant in Geismar on 11 November, a project carrying a total investment of around $1 billion. The site's annual production capacity now stands at roughly 600,000 tonnes.
Agricultural pipeline eyed for 2028
Further out, BASF Agricultural Solutions is targeting launches of its soybean resistance technology Nemasphere in the US and Brazil from 2028. On 16 November the company put the peak sales potential at more than €300 million. An EU import approval, according to BASF, completes the permits currently required across key export markets.
Ad
BASF Stock: New Analysis - 22 November
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
